← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Athersys, Inc.
Cleveland, OH
$8,020,484
Total funding
16
Grants
Funding over time
peak $1.3M · FY2006–17$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$7,937,076 · 15
DOD$83,408 · 1
By mechanism
R44$2,772,410 · 2
R42$2,163,044 · 2
U44$1,855,218 · 1
R43$1,009,904 · 9
R41$136,500 · 1
—$83,408 · 1
Investigators at Athersys, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Cell Based Therapy for Treatment of Traumatic Brain Injury$959,795
U44 · FY2013 · NS
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for$865,500
R44 · FY2015 · HL
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for$842,506
R44 · FY2016 · HL
Cell Based Therapy for Treatment of Traumatic Brain Injury$595,424
U44 · FY2014 · NS
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$450,040
R42 · FY2016 · AA
Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury$392,223
R42 · FY2010 · NS
Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury$392,223
R42 · FY2009 · NS
Genome-Wide Growth Factor Discovery in the CNS$385,357
R44 · FY2003 · NS
Genome-Wide Growth Factor Discovery in the CNS$349,047
R44 · FY2004 · NS
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for$330,000
R44 · FY2013 · HL
Cell Based Therapy for Treatment of Traumatic Brain Injury$299,999
U44 · FY2012 · NS
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$293,537
R42 · FY2017 · AA
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$224,721
R42 · FY2014 · AA
Combinatorial Treatment of Acute Spinal Cord Injury with MultiStem Cell Therapy and Intracellular Sigma Peptide$212,796
R43 · FY2015 · NS
Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury$205,471
R42 · FY2007 · NS
Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury$204,829
R42 · FY2009 · NS
Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury$136,500
R41 · FY2006 · NS
In-vitro generation of cardiomyocytes from MAPC$100,000
R43 · FY2004 · HL
Development of NFkappaB Inhibitors$99,990
R43 · FY2004 · CA
Small Molecular Inhibitors of Artemis as Radiosensitizer$99,944
R43 · FY2004 · CA